₃Christelle Tardy

Summary for 2004 [at-glance overview of Christelle Tardy work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Christelle Tardy. According to available data, in 2004 Christelle Tardy published at least 3 articles. This work was completed in collaboration with several authors including Bailly, Christian and Baldeyrou, Brigitte. Many other authors have collaborated with Christelle Tardy as well. There is no information about the funding or the grants awarded to support this work.

Christelle Tardy has rank 632 when compared to all other authors using the keyword DNA. Analysis of the article abstracts and the titles suggests that Christelle Tardy professional interests are focused around "i-mediated dna cleavage", "topoisomerase i-mediated dna" and "development antitumor agents". These might also be referred to as "antitumor agents", "guide development" or "i-mediated dna". Statistical analysis shows that Christelle Tardy's writing is likely to contains terms "dna", "compounds", "topoisomerase", "antitumor", "binding" and "derivatives".

The majority of Christelle Tardy articles are affiliated with INSERM U-524 et UR-524 and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France. Sadly, no email addresses were found for any of the affiliations.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Christelle Tardy]

Do you know Christelle Tardy who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Christelle Tardy]

none

Year 2004 Charts [Christelle Tardy frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Christelle Tardy publication and funding history for the range of years]

Christelle Tardy Coauthors (23) [all coauthors with the number of joint publications]

explore visually

Other [context-specific ads]

Affiliations (2) [condensed summary of the Christelle Tardy affiliations, the leading number and the color conveys importance]

₂INSERM U-524 et UR-524 and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045 Lille, France.
₁Institut de Chimie Organique et Analytique UMR-CNRS 6005, UFR de Sciences, Université d'Orléans, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France.

Key Opinion Leader In [Christelle Tardy is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₆₃₂DNA

Keywords (32) [keywords assigned to Christelle Tardy articles by PubMed, the leading number and the color conveys importance]

₃DNA | ₃Humans | ₂Cell Line, Tumor | ₂Animals | ₂DNA Topoisomerases, Type I | ₂Drug Screening Assays, Antitumor | ₂Heterocyclic Compounds with 4 or More Rings | ₂Antineoplastic Agents | ₂Structure-Activity Relationship | ₂Intercalating Agents | ₁Base Sequence | ₁Esters | ₁Dose-Response Relationship, Drug | ₁Drug Delivery Systems | ₁Leukemia P388 | ₁Carbazoles | ₁Polydeoxyribonucleotides | ₁Dihydropyridines | ₁DNA Topoisomerases, Type II | ₁Nucleic Acid Denaturation | ₁Circular Dichroism | ₁Molecular Sequence Data | ₁Alkaloids | ₁DNA Topoisomerases | ₁Drug Design | ₁Poly dA-dT | ₁Amino Acids | ₁Mice | ₁Deoxyribonuclease I | ₁Surface Plasmon Resonance | ₁Molecular Structure | ₁Pyrazines

Christelle Tardy Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Christelle Tardy might be a good expert witness on these terms]

₂₆dna | ₁₀compounds | ₉topoisomerase | ₈antitumor | ₈binding | ₇derivatives | ₅interaction | ₅molecules | ₅dimeric | ₅agents | ₅cytotoxic | ₄development | ₄strongly | ₄sequence | ₃i-mediated | ₃recognition | ₃cleavage | ₃lamellarin | ₃guide | ₃targeting | ₃studies | ₃sequences | ₃series | ₃novel | ₃dichroism | ₃amino | ₃acid | ₃variety | ₃dihydrodipyridopyrazines | ₃bisphenylcarbazole | ₃derived | ₃experiments
₅antitumor agents | ₃guide development | ₃i-mediated dna | ₃dna cleavage | ₃topoisomerase i-mediated | ₃amino acid | ₃dna binding | ₃dimeric dihydrodipyridopyrazines | ₂derived marine | ₂derivatives incorporating | ₂agents derived | ₂cleavage guide | ₂dna novel | ₂biochemical biophysical | ₂linear dichroism | ₂targeting dna | ₂acid residues | ₂dna interaction | ₂novel diphenylcarbazoles | ₂lamellarin triester | ₂development antitumor | ₂marine alkaloid | ₂binding sequences | ₂incorporating amino | ₂alkaloid lamellarin | ₂triester derivatives | ₂monomeric dimeric | ₂interaction dna | ₂dna sequence | ₂binding cytotoxic | ₂cytotoxic compounds | ₂mono bisdihydrodipyridopyrazines
₃i-mediated dna cleavage | ₃topoisomerase i-mediated dna | ₂development antitumor agents | ₂derived marine alkaloid | ₂guide development antitumor | ₂triester derivatives incorporating | ₂derivatives incorporating amino | ₂agents derived marine | ₂cleavage guide development | ₂antitumor agents derived | ₂dna novel diphenylcarbazoles | ₂alkaloid lamellarin triester | ₂amino acid residues | ₂marine alkaloid lamellarin | ₂dna cleavage guide | ₂incorporating amino acid | ₂lamellarin triester derivatives | ₂targeting dna novel | ₂bisdihydrodipyridopyrazines assessment dna | ₂mono bisdihydrodipyridopyrazines assessment | ₂monomeric dimeric dihydrodipyridopyrazines | ₂assessment dna binding | ₂dna binding cytotoxic | ₂synthesis mono bisdihydrodipyridopyrazines | ₂binding cytotoxic properties | ₁presence positive charges | ₁substitutions bisphenylcarbazole core | ₁dichroism dna relaxation | ₁hydroxyl groups strongly | ₁affinity compound dna | ₁cytotoxic compounds correspond | ₁corresponding cationic compounds

Reader's Comments (0) [comments posted by readers of Christelle Tardy profile]